Claudia Pessoa Selected Research

Claudia Pessoa Research Topics

Disease

40	Neoplasms (Cancer) 05/2022 - 11/2007
6	Leukemia 01/2020 - 02/2010
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2012
5	Melanoma (Melanoma, Malignant) 10/2016 - 11/2007
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2012
3	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2014
3	Carcinogenesis 01/2021 - 10/2010
2	Sarcoma 180 01/2021 - 08/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2020 - 01/2020
2	Infections 03/2012 - 07/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 12/2011 - 05/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hypoxia (Hypoxemia) 02/2020
1	Dyslipidemias (Dyslipidemia) 09/2019
1	Chronic Disease (Chronic Diseases) 09/2019
1	Inflammation (Inflammations) 09/2019
1	Hemorrhage 09/2019
1	Tuberculosis (Tuberculoses) 12/2016
1	Hemolysis 01/2014

Drug/Important Bio-Agent (IBA)

6	beta-lapachoneIBA 10/2017 - 11/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
4	quinone (benzoquinone)IBA 10/2021 - 10/2016
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2007
4	Volatile Oils (Essential Oils)IBA 09/2019 - 12/2011
3	NaphthoquinonesIBA 01/2021 - 05/2010
3	QuinonesIBA 05/2018 - 11/2007
2	Monoclonal AntibodiesIBA 01/2021 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2021
2	AlkaloidsIBA 01/2021 - 07/2002
2	HydrazonesIBA 01/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 03/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2014
2	Isoniazid (Ftivazide)FDA LinkGeneric 12/2016 - 01/2014
2	TubulinIBA 10/2013 - 06/2012
1	AndrogensIBA 05/2022
1	Panitumumab (Vectibix)FDA Link 01/2021
1	nimotuzumabIBA 01/2021
1	necitumumabIBA 01/2021
1	LipidsIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	pyrimidineIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	pyrazoleIBA 01/2021
1	H19 long non-coding RNAIBA 01/2021
1	Biological ProductsIBA 01/2021
1	AntigensIBA 01/2021
1	NitrogenIBA 10/2020
1	BromidesIBA 08/2020
1	Biocompatible Materials (Biomaterials)IBA 08/2020
1	LigandsIBA 02/2020
1	secnidazoleIBA 02/2020
1	ThiosemicarbazonesIBA 02/2020
1	Tirapazamine (SR 4233)IBA 02/2020
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 01/2020
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 01/2020
1	ethyl acetateIBA 01/2020
1	diphenyl (biphenyl)IBA 01/2020
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2020
1	Betulinic AcidIBA 01/2020
1	Methanol (Carbinol)IBA 01/2020
1	AntioxidantsIBA 01/2020
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2020
1	Methylene Chloride (Dichloromethane)IBA 01/2020
1	QuinoxalinesIBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	AlbuminsIBA 09/2019
1	Alkaline PhosphataseIBA 09/2019
1	Complex MixturesIBA 07/2019
1	Taxoids (Taxanes)IBA 12/2018
1	Vinca AlkaloidsIBA 12/2018
1	Acetates (Acetic Acid Esters)FDA Link 05/2018
1	lawsoneIBA 05/2018
1	Capsules (Microcapsules)IBA 10/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2017
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2017
1	Antitubercular AgentsIBA 12/2016
1	CopperIBA 10/2016
1	Alkynes (Acetylenes)IBA 10/2016
1	SeleniumIBA 10/2016
1	AzidesIBA 10/2016
1	Clerodane DiterpenesIBA 06/2016
1	Thalidomide (Thalomid)FDA Link 09/2015
1	BoronIBA 06/2015
1	biflorinIBA 12/2014
1	1,2-naphthoquinoneIBA 12/2014
1	1,4-naphthoquinoneIBA 08/2014
1	oxazolidineIBA 01/2014
1	Mefloquine (Lariam)FDA LinkGeneric 01/2014
1	QuinolinesIBA 01/2014
1	(4- methoxyphenyl)(3,4,5- trimethoxyphenyl)methanoneIBA 10/2013
1	piperlongumineIBA 02/2013

Therapy/Procedure

8	Therapeutics 05/2022 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2021
1	Phytotherapy (Herbal Therapy) 01/2020
1	Injections 09/2019
1	Ayurvedic Medicine (Siddha Medicine) 02/2013